Error: Could not add to watchlist. X
+ Watchlist

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

FBDIX:US
NASDAQ GM
133.34
USD
1.45
1.10%
As of 9:29 AM EDT 5/27/2016
Fund Type
Open-End Fund
52Wk Range
114.87 - 198.99
1 Yr Return
-27.70%
YTD Return
-18.47%
Previous Close
131.89
52Wk Range
114.87 - 198.99
1 Yr Return
-27.13%
YTD Return
-18.47%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 05/27/2016)
133.34
Total Assets (b USD) (on 04/29/2016)
1.193
Inception Date
09/15/1997
Last Dividend (on 12/15/2015)
3.8182
Dividend Indicated Gross Yield
-
Fund Managers
EVAN MCCULLOCH
Front Load Fee
5.75%
Back Load Fee
1.00%
Redemption Fee
0.00%
12b-1 Fee
0.25%
Current Mgmt Fee
0.57%
Expense Ratio
1.00%

Top Fund Holdings

Name Position Value % of Fund
1.23 m 123.48 m 10.64
1.15 m 105.45 m 9.08
356.76 k 92.87 m 8.00
471.30 k 70.66 m 6.09
113.21 k 40.81 m 3.52
495.50 k 35.91 m 3.09
736.01 k 33.84 m 2.92
410.26 k 33.84 m 2.92
202.20 k 32.78 m 2.82
213.50 k 29.72 m 2.56
Profile
Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.
Address
One Franklin Parkway
Building 970, 1st Floor
San Mateo, CA 94403
Phone
(800) 632-2350